Planet Fitness, Inc. PLNT 深 滬
已收盤 08-01 16:00:00 美东时间
107.61
-1.580
-1.45%
華盛通- 最 高108.84
- 今 開108.53
- 成交量 115.91万股
- 最 低 106.27
- 昨 收 109.19
- 總市值 90.23亿
- 52周最高 114.47
- 市盈率 靜 53.68
- 換手率 1.38%
- 52周最低 77.77
- 委 比 97.50%
- 總股本 8385.12万
- 歷史最高 114.47
- 量 比 1.04
- 振 幅 2.35%
- 歷史最低 10.45
- 每 手 1
- 風險率 10.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Court strikes down FTC's 'click-to-cancel' rule for subscriptions
An appeals court has struck down the Federal Trade Commission's "click-to-cancel" rule requiring businesses to make it as easy for consumers to cancel subscriptions as it was to sign up, citing flaws ...
07-09 17:38
Pliant Therapeutics Provides Update on BEACON-IPF
Pliant Therapeutics announced the discontinuation of bexotegrast development in idiopathic pulmonary fibrosis (IPF) following unfavorable safety and efficacy results from the BEACON-IPF Phase 2b/3 trial. While the drug showed modest improvements in lung function, it posed increased risks of disease progression and adverse events. The company is focusing on its oncology program, with PLN-101095 entering Phase 1 trials, and leveraging its proprieta...
06-27 20:05
美股大行评级 | 潜在涨幅超50%，数十家机构大幅上调甲骨文目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140203048973164544.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：上调Datavault AI(DVLT)评级至"买入"，目标价3美元</p> <p>• 蒙特利尔银行：维持DoubleVerify Holdings(DV)"跑赢大市"评级，目标价从25美元升至26
06-13 09:33
Canaccord Genuity Maintains Buy on Planet Fitness, Raises Price Target to $126
Canaccord Genuity analyst Brian McNamara maintains Planet Fitness (NYSE:PLNT) with a Buy and raises the price target from $120 to $126.
06-12 22:27
What's Driving the Market Sentiment Around Planet Fitness?
Planet Fitness's (NYSE:PLNT) short percent of float has risen 20.69% since its ...
05-31 04:00
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
Stifel Upgrades Planet Fitness to Buy, Raises Price Target to $120
Stifel analyst Chris O'Cull upgrades Planet Fitness (NYSE:PLNT) from Hold to Buy and raises the price target from $82 to $120.
05-22 21:51
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
